Hicham Alaoui, Ph.D. has been appointed to the newly created position of vice president, Biotherapeutics R&D, Codexis, Inc.   Dr. Alaoui brings unique drug discovery skills as the company expands its Biotherapeutics business and works to follow recent success in bringing its first drug candidate, CDX-6114 for potential treatment of phenylketonuria (PKU), into early trials. Dr. Alaoui will be responsible for directing the biotherapeutics discovery pipeline and for the acceleration of drug c...